Literature DB >> 6323542

Distribution of the Ca (Oxford) antigen in lung neoplasms and non-neoplastic lung tissues.

F J Paradinas, G Boxer, K D Bagshawe.   

Abstract

The Ca (Oxford) antigen was originally isolated from a malignant neoplasm and with few exceptions was reported to discriminate between malignant and non-malignant neoplasms or normal tissues. Using the Ca 1 antibody we have studied the Ca distribution in 54 lung neoplasms and adjacent non-neoplastic lung tissue. Staining of tumours was very focal and the proportion of positive cells varied from about 50% for adenocarcinomas to less than 1% for oat cell carcinomas, which were often negative. Focal cytoplasmic staining can be seen in all neoplasms, whereas membrane staining is mainly seen in their areas of glandular and squamous differentiation. We found consistently strong membrane staining of alveolar type II pneumocytes in non-neoplastic lung. This staining may be useful in differentiating type II cells from alveolar macrophages which only occasionally showed granular cytoplasmic staining, probably due to phagocytosed Ca. Mucin from tumours and bronchi did not stain but there was consistent staining of alveolar serous exudate suggesting extracellular location of Ca.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323542      PMCID: PMC498607          DOI: 10.1136/jcp.37.1.1

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Transformation of alveolar type 2 cells to type 1 cells following exposure to NO2.

Authors:  M J Evans; L J Cabral; R J Stephens; G Freeman
Journal:  Exp Mol Pathol       Date:  1975-02       Impact factor: 3.362

2.  Experience with the Oxford tumour marker (Ca1) in serous fluids.

Authors:  G Pallesen; F L Jepsen; J Hastrup; A Ipsen; N Hvidberg
Journal:  Lancet       Date:  1983-06-11       Impact factor: 79.321

3.  Evaluation of Cal antibody in pleural biopsy material.

Authors:  R A Burnett; A R Deery; M R Adamson; C Liddle; M Thomas; G H Roberts
Journal:  Lancet       Date:  1983-05-21       Impact factor: 79.321

4.  A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with the Ca1 antibody.

Authors:  J C Woods; A I Spriggs; H Harris; J O McGee
Journal:  Lancet       Date:  1982-09-04       Impact factor: 79.321

5.  Distribution of epithelial membrane antigen in normal and neoplastic tissues and it value in diagnostic tumor pathology.

Authors:  J P Sloane; M G Ormerod
Journal:  Cancer       Date:  1981-04-01       Impact factor: 6.860

6.  A new marker for human cancer cells. 1 The Ca antigen and the Ca1 antibody.

Authors:  F Ashall; M E Bramwell; H Harris
Journal:  Lancet       Date:  1982-07-03       Impact factor: 79.321

7.  A new marker for human cancer cells, 2 immunohistochemical detection of the Ca antigen in human tissues with the Ca1 antibody.

Authors:  J O McGee; J C Woods; F Ashall; M E Bramwell; H Harris
Journal:  Lancet       Date:  1982-07-03       Impact factor: 79.321

8.  The use of antisera to epithelial membrane antigen in detecting micrometastases in histological sections.

Authors:  J P Sloane; M G Ormerod; S F Imrie; R C Coombes
Journal:  Br J Cancer       Date:  1980-09       Impact factor: 7.640

9.  Structure and function of the Ca antigen.

Authors:  M E Bramwell; V P Bhavanandan; G Wiseman; H Harris
Journal:  Br J Cancer       Date:  1983-08       Impact factor: 7.640

10.  Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen.

Authors:  D P Dearnaley; J P Sloane; M G Ormerod; K Steele; R C Coombes; H M Clink; T J Powles; H T Ford; J C Gazet; A M Neville
Journal:  Br J Cancer       Date:  1981-07       Impact factor: 7.640

  10 in total
  10 in total

1.  Genital infections due to Neisseria meningitidis.

Authors:  I Thangkhiew; S M Drake; M Walzman; A A Wade
Journal:  Genitourin Med       Date:  1990-08

2.  Ca antigen and urothelial antibacterial defences: hypothesis.

Authors:  J A Morris; K Oates; W G Staff
Journal:  J Clin Pathol       Date:  1986-06       Impact factor: 3.411

3.  Survival of gram positive anaerobic cocci on swabs and their isolation from the mouth and vagina.

Authors:  G L Smith; C G Cumming; P W Ross
Journal:  J Clin Pathol       Date:  1986-01       Impact factor: 3.411

4.  Localisation of Ca and HMFG2 antigens in breast tissue by immunoperoxidase, immunofluorescence, and immunoelectron microscopy.

Authors:  U Beckford; C Barbatis; J E Beesley; J C Linsell; S M Chantler
Journal:  J Clin Pathol       Date:  1985-05       Impact factor: 3.411

5.  Use of monoclonal antibody against human neutrophil elastase in normal and leukaemic myeloid cells.

Authors:  K A Pulford; W N Erber; J A Crick; I Olsson; K J Micklem; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

6.  Isolation and chemical and immunochemical characterization of the peanut-lectin-binding glycoprotein from human milk-fat-globule membranes.

Authors:  J Fischer; P J Klein; G H Farrar; F G Hanisch; G Uhlenbruck
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

7.  14C-urea breath test in C pylori gastritis.

Authors:  E A Rauws; E A Royen; W Langenberg; J V Woensel; A A Vrij; G N Tytgat
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

8.  Changes in plasma beta 2 microglobulin concentrations after allogeneic bone marrow transplantation.

Authors:  D R Norfolk; M A Forbes; E H Cooper; J A Child
Journal:  J Clin Pathol       Date:  1987-06       Impact factor: 3.411

9.  Distribution of IgA1 and IgA2 subclasses in normal bone marrow trephines and in trephines infiltrated by IgA producing multiple myeloma.

Authors:  P Lenormand; J Crocker
Journal:  J Clin Pathol       Date:  1987-02       Impact factor: 3.411

10.  Immunocytochemical reaction of Ca1 and HMFG2 monoclonal antibodies with cells from serous effusions.

Authors:  S Singer; M M Boddington; E A Hudson
Journal:  J Clin Pathol       Date:  1985-02       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.